Friess Associates’s Artivion AORT Stock Holding History

Friess Associates’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-64,590	Closed	-$1.07M	–	104
2017 Q1	$1.07M	Buy	64,590 +24,590	+61%	+$434K	0.1%	99
2016 Q4	$766K	Buy	+40,000	New	+$729K	0.08%	95

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Friess Associates's AORT Position: Q2 2017 in Review

Friess Associates sold out of Artivion (AORT) in Q2 2017, closing a stake of 64,590 shares — an estimated $1.07M sold.

Friess Associates first reported a position in AORT in Q4 2016 and held it in 2 quarters. The position peaked at $1.07M in Q1 2017. 127 funds tracked by Wall St. Rank hold AORT as of Q2 2017.

Friess Associates reported no remaining Artivion position as of Q2 2017 after selling out during the quarter.
Friess Associates sold 64,590 Artivion shares in Q2 2017, an estimated $1.07M.
Friess Associates first reported a position in Artivion in Q4 2016 and held it in 2 quarters.
Friess Associates's Artivion position peaked at $1.07M in Q1 2017.
127 funds tracked by Wall St. Rank held Artivion as of Q2 2017.

Based on Friess Associates's 13F filing for Q2 2017, filed 14 Aug 2017.